The Canadian Coordinating Office for Health Technology Assessment (CCOHTA) has just released the 2nd edition of Guidelines for Economic Evaluation of Pharmaceuticals: Canada. The Guidelines provide a standard framework for pharmaceuticals study design and reporting format and are directed at researchers who conduct health economic evaluations. The report "focuses on key areas of significant development in theory and/or methodology such as cost-benefit analysis, equity, utilities, and treatment comparators."
Comments